Infectious Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular targets involved in infectious disorders, e.g. disease disease-specific proteins, receptors, enzymes and genes. Each issue of the journal contains a series of timely, in-depth reviews/mini-reviews and research articles written by leaders in the field, covering a range of current topics on drug targets involved in infectious disorders. As the discovery, identification, characterization and validation of novel drug targets for anti-infective drug discovery continue to grow, this journal will be essential reading for all pharmaceutical scientists involved in drug design, discovery and development. All aspects of the epidemiology, pathogenesis, clinical relevance, theranostics, as well as preventive measures related to infectious disorders caused by bacteria, fungi, parasites, viruses, HIV and other sexually transmitted diseases (STDs) are also included in the scope of the journal.

Infectious Disorders - Drug Targets is an international, peer-reviewed journal on all aspects of drug targets involved in infectious disorders, published bi-monthly (print & online) by Bentham Science Publishers.